Physician profile
Jaideep H Mehta
NPI 1841459021
$134,044.19
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,279 · 2020: $6,522 · 2021: $99K · 2022: $22K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acacia Pharma INC | $104,755.77 | 2021-2022 | |
| Mml US, INC. | $10,156.16 | 2021-2022 | |
| Abbott Laboratories | $4,272.80 | 2019-2022 | |
| Heron Therapeutics, INC. | $3,997.97 | 2019-2021 | |
| Boston Scientific Corporation | $2,449.23 | 2020-2022 | |
| Vertos Medical, INC. | $1,879.56 | 2020-2022 | |
| Medtronic USA, INC. | $1,786.92 | 2019-2020 | |
| Nevro Corp. | $966.24 | 2019-2021 | |
| Flowonix Medical Incorporated | $828.72 | 2020 | |
| Relievant Medsystems, INC. | $656.26 | 2021 | |
| Medtronic, INC. | $631.00 | 2021-2022 | |
| Si-Bone, INC. | $277.18 | 2020 | |
| Spr Therapeutics, INC | $197.21 | 2019-2021 | |
| Nalu Medical, INC. | $162.78 | 2021-2022 | |
| Spinal Simplicity, LLC | $133.45 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $129.28 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $123.11 | 2021 | |
| Covidien Lp | $116.89 | 2019 | |
| Merck Sharp & Dohme LLC | $95.02 | 2019 | |
| Abbvie INC. | $70.10 | 2021-2022 | |
| Allergan, INC. | $65.93 | 2021-2022 | |
| Stryker Corporation | $55.28 | 2019 | |
| Biodelivery Sciences International, INC. | $49.98 | 2020 | |
| Arbor Pharmaceuticals, INC. | $45.20 | 2021 | |
| Pacira Therapeutics, INC. | $36.13 | 2020 | |
| Grt US Holding, INC. | $32.79 | 2021-2022 | |
| Biotissue Holdings INC. | $23.21 | 2021 | |
| Collegium Pharmaceutical, INC. | $20.20 | 2021 | |
| Scilex Pharmaceuticals INC. | $15.66 | 2019 | |
| Depuy Synthes Sales INC. | $14.16 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaideep Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.